Contraceptive Market Outlook 2031
The Global Contraceptive Market size was valued at USD 28.30 Billion in 2022 and is likely reach to USD 48.06 Billion by 2031, expanding at a CAGR of 6.06% during the forecast period, 2023–2031. The growth of the market is attributed to the high prevalence of sexually transmitted diseases and increasing awareness among the population regarding the contraceptive drugs.
Contraception is a technique of inhibiting pregnancy with the use of devices or drugs. It is also called as fertility control and birth control method or technique, which are widely used to prevent pregnancy. There are various types of contraceptive options available in the market with different techniques of preventing pregnancy.
The drugs or devices involved in contraception hinder the normal procedure of fertilization of ovum by sperm to prevent pregnancy. The two techniques of contraception are devices and oral. The fertility control avoids pregnancy by disturbing the normal procedure of fertilization, ovulation, and implantation.
Women’s menstruation cycle causes the ovum to release every month, which makes them fertile to become pregnancy. The menstrual cycle causes the uterus to develop the inner lining of the uterus that makes it ready to conceive a baby. Birth control drugs or devices are developed to interrupt the normal route to prevent the potential pregnancy.
The different contraceptives acts at specific places in the process, starting from ovulation via fertilization till implantation.
As per the U.S. Centers for Disease Control and Prevention (CDC), the reports suggest that in the US nearly 37% of the birth is due to unwanted pregnancy, a quantity that has remained constant since 1982. The unwanted pregnancy is a key factor that drive the market as contraceptives are used to prevent that unwanted pregnancies.
The COVID-19 pandemic outbreak has impacted the global market in a negative manner as the pandemic had resulted into restrictions all around the world and national wide lockdowns.
The restriction caused the disturbance in the supply chain of the products as well as reduced focus on other items than COVID-19 related products. This caused the contraceptive market to slow down its growth during the pandemic.
Market Trends, Drivers, Restraints, and Opportunities
- Rising government initiatives for reducing sexually transmitted diseases as well as beneficial policies for contraceptive manufacturing companies are driving the market growth.
- Growing focus of a large number of the global population on family planning and prevention of unwanted pregnancy are pushing the market in the positive direction of growth.
- Certain side effects of using the oral contraceptives and adverse effects that can weaken the normal delivery of women in later development are hindering the market growth.
- Lack of social acceptance towards the use of contraceptives in the developing or underdeveloped countries is restricting the market development.
- High prevalence of sexually transmitted diseases and increase development of new contraceptives are offering huge opportunities for the market expansion in the coming years.
Scope of Contraceptive Market Report
The report on the global contraceptives market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Contraceptives Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2022
|
|
Historic Data
|
2016–2021
|
|
Forecast Period
|
2023–2031
|
|
Segmentation
|
Products (Contraceptive Drugs [Contraceptive Pills, Topical, and Injectable] and Contraceptive Devices [Male Condoms, Female Condoms, Vaginal Implants, Subdermal Implants, Diaphragms, Sponges, and IUDs {Copper IUD and Hormonal IUD}])
|
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
Teva Pharmaceutical Industries; The Female Health Company; Reckitt Benckiser Plc; Pfizer Inc.; Church & Dwight, Mayer Laboratories; Cooper Surgical; Actavis plc; and Merck & Co.
|
Contraceptive Market Segment Insights
Contraceptive devices segment is expected to grow at a rapid pace
Based on products, the global contraceptive market is bifurcated into contraceptive drugs and contraceptive devices. The contraceptive drugs segment is further divided into contraceptive pills, topical, and injectable. The contraceptive devices segment is also classified as male condoms, female condoms, vaginal implants, subdermal implants, diaphragms, sponges, and IUDs.
The IUDs segment is further bifurcated into copper IUD and hormonal IUD. The contraceptive devices segment is expected to grow at a rapid pace during the projected period owing to the high demand for condoms both of male and female as they are easily available and easy to use.
Governments across the globe have also launched several policies to promote the use of condom so that the infections spread can be kept under control.
The IUDs segment is projected to hold a key share within the segment growth due to the high acceptance of the products by doctors as an effective and safe method. Some of the IUDs commonly used are Nova-T, Paragard, Skyla, Flexi-T, Jaydess, Mirena, and others.
The contraceptive drugs segment, however, is anticipated to grow at a robust pace in the coming years as there is extensive research activities going on in this field of drugs development. Other factors including high number of the women population with reproductive age, government policies, large usage, and great consumer base are expected to push the segment growth.
These drugs includes the hormones that prevent the development of embryo if fertilization occur as well as it can kill the sperms if entered the body through sex.
Contraceptive Market Regional Outlook
North America is anticipated to constitute a key market share
In terms of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to constitute a key market share during the forecast period attributed to increasing cases of live-in relationship and rising population of young girls becoming pregnant during college life.
Furthermore, high awareness in the population regarding the use of contraceptives and birth control measures with highly skilled healthcare professionals present another key drivers of the regional market growth.
Good government programs and social acceptance in the region for the use of contraceptives is bolstering the region’s position to growth during the forecast period. Latin America is anticipated to hold a major share of the market in the coming years owing to the large untapped population, the developing healthcare facilities, and increasing people awareness.
Meanwhile, the market of Asia Pacific is projected to exhibit a high CAGR during the forecast period as the region has very high population and government efforts towards increasing awareness among the people using contraceptives.
Segments
Products
- Contraceptive Drugs
- Contraceptive Pills
- Topical
- Injectable
- Contraceptive Devices
- Male Condoms
- Female Condoms
- Vaginal Implants
- Subdermal Implants
- Diaphragms
- Sponges
- IUDs
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
Competitive Landscape
The key players competing in the global contraceptives market are Teva Pharmaceutical Industries; Reckitt Benckiser Plc; Cooper Surgical; Pfizer Inc.; The Female Health Company; Actavis plc; Church & Dwight, Mayer Laboratories; and Merck & Co.
Request For Customization
Enquiry Before Buying
Speak With Analyst
